Janus Henderson Group’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,092,212
| Closed | -$9.22M | – | 2588 |
|
|
2022
Q2 | $9.22M | Sell |
1,092,212
-909,230
| -45% | -$7.67M | 0.01% | 711 |
|
|
2022
Q1 | $27.2M | Buy |
2,001,442
+160,085
| +9% | +$2.18M | 0.01% | 676 |
|
|
2021
Q4 | $36.2M | Sell |
1,841,357
-106,645
| -5% | -$2.1M | 0.02% | 644 |
|
|
2021
Q3 | $62.5M | Sell |
1,948,002
-3,632
| -0.2% | -$117K | 0.03% | 488 |
|
|
2021
Q2 | $66.1M | Sell |
1,951,634
-2,814
| -0.1% | -$95.3K | 0.03% | 495 |
|
|
2021
Q1 | $73.4M | Buy |
1,954,448
+16,012
| +0.8% | +$601K | 0.03% | 449 |
|
|
2020
Q4 | $64.4M | Buy |
1,938,436
+369,640
| +24% | +$12.3M | 0.03% | 479 |
|
|
2020
Q3 | $57.5M | Sell |
1,568,796
-9,883
| -0.6% | -$362K | 0.03% | 465 |
|
|
2020
Q2 | $52M | Sell |
1,578,679
-88,898
| -5% | -$2.93M | 0.03% | 479 |
|
|
2020
Q1 | $42.2M | Buy |
1,667,577
+200,115
| +14% | +$5.06M | 0.03% | 494 |
|
|
2019
Q4 | $43.6M | Buy |
+1,467,462
| New | +$43.6M | 0.02% | 632 |
|